Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | CA1 | P00915 | 3/20 | 0.60 |
| ▸ | CA2 | P00918 | 3/20 | 0.60 |
| ▸ | CA12 | O43570 | 2/20 | 0.60 |
| ▸ | CA9 | Q16790 | 2/20 | 0.60 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP7 | P09237 | 1/20 | 0.50 |
| ▸ | MMP14 | P50281 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | PARL | Q9H300 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21993320 | 1.00 | ALDH1A1 (0.71) | ALDH1A1HSD17B10TDP1CA1CA2 | |
| Hydrochloric Acid SCHEMBL5174554 | 0.98 | ALDH1A1 (0.68) | ALDH1A1HSD17B10TDP1CA1CA2 | |
| SCHEMBL5891023 | 0.89 | ALDH1A1 (0.60) | ALDH1A1HSD17B10TDP1CA1CA2 | |
| SCHEMBL150162 | 0.89 | ALDH1A1 (0.60) | ALDH1A1HSD17B10TDP1CA1CA2 | |
| SCHEMBL18424824 | 0.89 | PTGS2 (0.64) | ALDH1A1HSD17B10TDP1CA1CA2 | |
| SCHEMBL9539212 | 0.88 | ALDH1A1 (0.56) | ALDH1A1HSD17B10TDP1CA1CA2 | |
| Water SCHEMBL7024182 | 0.87 | ALDH1A1 (0.57) | ALDH1A1HSD17B10TDP1CA1CA2 | |
| SCHEMBL10704793 | 0.84 | TDP1 (1.00) | ALDH1A1HSD17B10TDP1CA1CA2 | |
| SCHEMBL17223 | 0.84 | TDP1 (1.00) | ALDH1A1HSD17B10TDP1CA1CA2 | |
| Benzene SCHEMBL4292987 | 0.84 | TDP1 (1.00) | ALDH1A1HSD17B10TDP1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125650-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES | TRAILHEAD BIOSYSTEMS INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4720316-A2 | NON-VIRAL CELL ENGINEERING | Arsenal Biosciences, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4692062-A1 | NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME | Amorepacific Corporation (KR) | 2026-02-11 | — | — | EP | claimed |
| US-20250115871-A1 | METHODS TO IMPROVE ENDURING HEMATOPOIETIC STEM CELL TRANSPLANTATION | TRAILHEAD BIOSYSTEMS INC. | 2025-04-10 | — | — | US | claimed |
| WO-2024259376-A2 | NON-VIRAL CELL ENGINEERING | ARSENAL BIOSCIENCES, INC. (US) | 2024-12-19 | — | — | WO | claimed |
| EP-4441205-A1 | METHODS AND COMPOSITIONS FOR MAINTAINING AND EXPANDING HEMATOPOIETIC STEM CELLS | Trailhead Biosystems Inc. (US) | 2024-10-09 | — | — | EP | claimed |
| WO-2024205303-A1 | NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME | (주)아모레퍼시픽 | 2024-10-03 | — | — | WO | claimed |
| CN-118302519-A | Methods and compositions for maintaining and expanding hematopoietic stem cells | 特雷尔赫德生物系统股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| US-20230310479-A1 | LOW DOSE ADJUVANT EPIGENETIC CANCER THERAPY | UNIV JOHNS HOPKINS (US) | 2023-10-05 | — | — | US | claimed |
| WO-2023143608-A1 | COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF | 上海复东生物医药有限责任公司 | 2023-08-03 | — | — | WO | claimed |
| CN-106188950-A | A kind of pvc sheath compensating cable | 张翔 | 2016-12-07 | — | — | CN | claimed |
| US-20140364566-A1 | SCALE-UP PROCESS OF BIFUNCTIONALIZED TRIBLOCK COPOLYMERS WITH SECONDARY AND TERTIARY AMINES, WITH APPLICATION IN DEWATERING AND DESALTING OF HEAVY CRUDE OILS | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2014-12-11 | — | — | US | claimed |
| WO-2014042603-A1 | ENHANCED THERMAL STABILITY POLYALKYLENE CARBONATE COMPOSITION AND A PREPARATION METHOD THEREOF | PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED (TH) | 2014-03-20 | — | — | WO | claimed |
| WO-2012160452-A1 | TWO-PART POLYMERISABLE COMPOSITIONS | HENKEL IRELAND LIMITED (IE) | 2012-11-29 | — | — | WO | claimed |
| EP-2385831-A2 | SMALL MOLECULE INHIBITORS OF NADS, NAMNAT, AND NMNAT | The UAB Research Foundation (US) | 2011-11-16 | — | — | EP | claimed |
| US-20110254866-A1 | INFORMATION PROCESSING APPARATUS, METHOD AND PROGRAM THEREFORE | SONY CORPORATION (JP) | 2011-10-20 | — | — | US | claimed |
| WO-2010123591-A2 | SMALL MOLECULE INHIBITORS OF NADS, NAMNAT, AND NMNAT | THE UAB RESEARCH FOUNDATION (US) | 2010-10-28 | — | — | WO | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| EP-1025081-B1 | S-(4-BIPHENYL)-THIOSULPHURIC ACIDS AND THEIR SALTS, METHOD FOR PRODUCING THE SAME AND METHOD FOR PRODUCING 4-MERCAPTOBIPHENYLS | BAYER AG (DE) | 2002-03-13 | — | — | EP | claimed |
| CN-1277603-A | S-(4-Biphenyl)-thiosulphuric acids and their salts method for producing the same and method for producing 4-mercaptobiphenyls | BAYER AG (DE) | 2000-12-20 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125650-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES | WNT3A, GSK3B, GSK3A | ALDH1A1 1732/4885HSD17B10 75/4885TDP1 4119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.